Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN13232859
ISRCTN13232859
Completed
未知

Take home naloxone Intervention Multicentre Emergency setting feasibility trial

Swansea University0 sites200 target enrollmentFebruary 16, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOpioid overdoseInjury, Occupational Diseases, PoisoningOther opioids

Overview

Phase
未知
Intervention
Not specified
Conditions
Opioid overdose
Sponsor
Swansea University
Enrollment
200
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2019 Protocol article in http://dx.doi.org/10.1136/emermed-2019-999.24 protocol (added 01/08/2019) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/39198758/ (added 02/09/2024)

Registry
who.int
Start Date
February 16, 2018
End Date
July 31, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Eligible for intervention:
  • •Adult (18 years of age or over, male or female) opioid users at risk of overdose who are attended by emergency ambulance paramedic or who attend ED
  • •Accompanying friends, relatives or carers (18 years of age or over, male or female) of opioid users at risk of overdose who are attended by emergency ambulance paramedic or who attend ED
  • •Eligible for inclusion in outcome follow up and analyses:
  • •High risk peers (18 years of age or over, male or female) \- opioid users at high risk of fatal opioid overdose who make up a wider peer group who may or may not make contact with emergency services at study site during the study period

Exclusion Criteria

  • •1\. Under 18 years of age
  • •2\. Actively dissent from involvement in study
  • •3\. Non\-opioid overdose

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Stimulation of the Tibial nerve – A Randomised Trial for Urinary problems associated with Parkinson’s disease (STARTUP)Parkinson’s disease with lower urinary tract symptomsNervous System Diseases
ISRCTN12437878Glasgow Caledonian University208
Completed
Phase 2
Systemic therapy and chemoradiation in advanced localised pancreatic cancer (SCALOP2)Pancreatic cancerCancerMalignant neoplasm of pancreas
ISRCTN50083238niversity of Oxford (UK)186
Completed
Not Applicable
Optimisation of perioperative cardiovascular management to improve surgical outcome II
ISRCTN39653756Queen Mary University of London2,502
Completed
Phase 3
ACTION: cancer patient involvement in medical decision makingTopic: CancerSubtopic: Colorectal Cancer, Lung CancerDisease: Colon, Lung (small cell), Lung (non-small cell)Cancer
ISRCTN63110516ancaster University (UK)1,117
Completed
Not Applicable
Metformin for Romanian patients with autosomal dominant polycystic kidney diseaseAutosomal Dominant Polycystic Kidney DiseaseGenetic Diseases
ISRCTN93749377Fundeni Clinical institute34